KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBT Margin (2016 - 2025)

Historic EBT Margin for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 21.64%.

  • Medpace Holdings' EBT Margin fell 6300.0% to 21.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.02%, marking a year-over-year increase of 11300.0%. This contributed to the annual value of 22.57% for FY2024, which is 47700.0% up from last year.
  • As of Q3 2025, Medpace Holdings' EBT Margin stood at 21.64%, which was down 6300.0% from 20.64% recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' EBT Margin ranged from a high of 24.95% in Q4 2024 and a low of 15.34% during Q2 2021
  • Over the past 5 years, Medpace Holdings' median EBT Margin value was 19.74% (recorded in 2022), while the average stood at 19.63%.
  • In the last 5 years, Medpace Holdings' EBT Margin crashed by -44500bps in 2023 and then surged by 67500bps in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' EBT Margin stood at 18.12% in 2021, then increased by 3bps to 18.69% in 2022, then dropped by -3bps to 18.2% in 2023, then skyrocketed by 37bps to 24.95% in 2024, then decreased by -13bps to 21.64% in 2025.
  • Its EBT Margin stands at 21.64% for Q3 2025, versus 20.64% for Q2 2025 and 21.16% for Q1 2025.